{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:23:14Z","timestamp":1782476594635,"version":"3.54.5"},"reference-count":21,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,5,10]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Mixed drug overdose presents a complex and potentially unpredictable clinical course, particularly in the presence of comorbidities that may alter drug metabolism, half-life and pharmacodynamic effects. We report a man in his 50s presenting with reduced consciousness, Glasgow Coma Scale (GCS) 11, requiring oxygen therapy after ingesting 100\u2009mg diazepam, 1200\u2009mg pregabalin and suspected co-ingestion of zopiclone and gabapentin. Flumazenil produced rapid but transient improvement. However, fluctuating consciousness persisted, with further deterioration in GCS on day 8 that again responded to flumazenil. He had liver fibrosis and a raised body mass index (33\u2009kg\/m\u00b2). Investigations revealed hyperammonaemia, mild diffuse encephalopathy on electroencephalogram (EEG) and faecal retention. CT head was unremarkable.<\/jats:p>\n                  <jats:p>The prolonged clinical course was likely multifactorial, reflecting synergistic central nervous system depressant effects in the context of polypharmacy, hepatic dysfunction, hyperammonaemia and obesity. This case highlights the importance of recognising mixed overdose and comorbid modifiers in prolonged complex toxic presentations.<\/jats:p>","DOI":"10.1136\/bcr-2025-270601","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:55:20Z","timestamp":1780070120000},"page":"e270601","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Prolonged and fluctuating consciousness after mixed overdose: navigating the complexities of polypharmacy, hepatic impairment and flumazenil use"],"prefix":"10.1136","volume":"19","author":[{"given":"Vi","family":"Truong","sequence":"first","affiliation":[{"name":"Medicine, MFT, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemantha","family":"Chandrasekara","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology, North Manchester General Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"2026052908550804000_19.5.e270601.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010538","article-title":"Epidemiology and trends in non-fatal self-harm in three centres in England, 2000-2012: findings from the Multicentre Study of Self-harm in England","volume":"6","author":"Geulayov","year":"2016","journal-title":"BMJ Open"},{"key":"2026052908550804000_19.5.e270601.2","unstructured":"Garza AZ , Park SB , Kocz R . Drug elimination. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2026. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547662\/"},{"key":"2026052908550804000_19.5.e270601.3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bcpt.12434","article-title":"Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication--A Systematic Review with Meta-Analyses of Randomised Trials","volume":"118","author":"Penninga","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026052908550804000_19.5.e270601.4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjms.2021.09.012","article-title":"Normal or near normal aminotransferase levels in patients with alcoholic cirrhosis","volume":"363","author":"Sullivan","year":"2022","journal-title":"Am J Med Sci"},{"key":"2026052908550804000_19.5.e270601.5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4292\/wjgpt.v8.i1.26","article-title":"Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity","volume":"8","author":"Telles-Correia","year":"2017","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"2026052908550804000_19.5.e270601.6","doi-asserted-by":"crossref","first-page":"115281","DOI":"10.1016\/j.biopha.2023.115281","article-title":"Pharmacokinetics of obese adults: Not only an increase in weight","volume":"166","author":"Gouju","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026052908550804000_19.5.e270601.7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2125.1982.tb01421.x","article-title":"Valproic acid and diazepam interaction in vivo","volume":"13","author":"Dhillon","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"2026052908550804000_19.5.e270601.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01474.x"},{"key":"2026052908550804000_19.5.e270601.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00655.x","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"114","author":"Segura-Bruna","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"2026052908550804000_19.5.e270601.10","article-title":"Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy","volume":"7","author":"Goh","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026052908550804000_19.5.e270601.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.186"},{"key":"2026052908550804000_19.5.e270601.12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/07853890.2019.1693056","article-title":"Impaired albumin function: a novel potential indicator for liver function damage?","volume":"51","author":"Sun","year":"2019","journal-title":"Ann Med"},{"key":"2026052908550804000_19.5.e270601.13","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021926405944"},{"key":"2026052908550804000_19.5.e270601.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2007.05.004"},{"key":"2026052908550804000_19.5.e270601.15","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2010.095075"},{"key":"2026052908550804000_19.5.e270601.16","article-title":"A Case Report of Continuous Flumazenil Infusion in a Nonagenarian With Benzodiazepine Toxicity, Managed Outside Intensive Care","volume":"17","author":"Romanello","year":"2025","journal-title":"Cureus"},{"key":"2026052908550804000_19.5.e270601.17","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2700.145422"},{"key":"2026052908550804000_19.5.e270601.18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1592\/phco.23.14.1513.31941","article-title":"Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity","volume":"23","author":"Maxa","year":"2003","journal-title":"Pharmacotherapy"},{"key":"2026052908550804000_19.5.e270601.19","article-title":"Continuous Intravenous Flumazenil Infusion Used in Iatrogenic Chlordiazepoxide Overdose in the Setting of Alcoholic Withdrawal Syndrome Management","volume":"12","author":"Volney","year":"2020","journal-title":"Cureus"},{"key":"2026052908550804000_19.5.e270601.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/24734306.2024.2395699","article-title":"Prolonged infusion of flumazenil for the reversal of sedation from chlordiazepoxide: a case report","volume":"8","author":"Spadaro","year":"2024","journal-title":"Toxicol Commun"},{"key":"2026052908550804000_19.5.e270601.21","doi-asserted-by":"crossref","DOI":"10.1097\/01.ccm.0000440490.85099.53","article-title":"Continuous infusion flumazenil for prolonged benzodiazepine-induced sedation","volume":"41 Suppl 12","author":"Nelson","year":"2013","journal-title":"Crit Care Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-270601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:55:23Z","timestamp":1780070123000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-270601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,29]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bcr-2025-270601"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-270601","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}